Homocysteine trials--clear outcomes for complex reasons - PubMed (original) (raw)

Editorial

. 2006 Apr 13;354(15):1629-32.

doi: 10.1056/NEJMe068060. Epub 2006 Mar 12.

• PMID: 16531615
• DOI: 10.1056/NEJMe068060

Editorial

Homocysteine trials--clear outcomes for complex reasons

Joseph Loscalzo. N Engl J Med. 2006.

No abstract available

PubMed Disclaimer

Comment in

• Homocysteine, B vitamins, and cardiovascular disease.
  Quinlivan EP, Gregory JF 3rd. Quinlivan EP, et al. N Engl J Med. 2006 Jul 13;355(2):206; author reply 209-11. N Engl J Med. 2006. PMID: 16838446 No abstract available.

Comment on

• Homocysteine lowering with folic acid and B vitamins in vascular disease.
  Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J Jr; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Lonn E, et al. N Engl J Med. 2006 Apr 13;354(15):1567-77. doi: 10.1056/NEJMoa060900. Epub 2006 Mar 12. N Engl J Med. 2006. PMID: 16531613 Clinical Trial.
• Homocysteine lowering and cardiovascular events after acute myocardial infarction.
  Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators. Bønaa KH, et al. N Engl J Med. 2006 Apr 13;354(15):1578-88. doi: 10.1056/NEJMoa055227. Epub 2006 Mar 12. N Engl J Med. 2006. PMID: 16531614 Clinical Trial.

Similar articles

• [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
  Strasser RH. Strasser RH. Internist (Berl). 2007 Mar;48(3):327-9. doi: 10.1007/s00108-007-1799-8. Internist (Berl). 2007. PMID: 17333057 German. No abstract available.
• Homocysteine, B vitamins, and cardiovascular disease.
  de Craen AJ, Stott DJ, Westendorp RG. de Craen AJ, et al. N Engl J Med. 2006 Jul 13;355(2):205-6; author reply 209-11. doi: 10.1056/NEJMc061259. N Engl J Med. 2006. PMID: 16837687 No abstract available.
• Homocysteine lowering and cardiovascular events after acute myocardial infarction.
  Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators. Bønaa KH, et al. N Engl J Med. 2006 Apr 13;354(15):1578-88. doi: 10.1056/NEJMoa055227. Epub 2006 Mar 12. N Engl J Med. 2006. PMID: 16531614 Clinical Trial.
• The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?
  Abraham JM, Cho L. Abraham JM, et al. Cleve Clin J Med. 2010 Dec;77(12):911-8. doi: 10.3949/ccjm.77a.10036. Cleve Clin J Med. 2010. PMID: 21147945 Review.
• [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
  Bendini MG, Lanza GA, Mazza A, Giordano A, Leggio M, Menichini G, De Cristofaro R, Moriconi E, Cozzari L, Farina SM, Giordano G. Bendini MG, et al. G Ital Cardiol (Rome). 2007 Mar;8(3):148-60. G Ital Cardiol (Rome). 2007. PMID: 17461357 Review. Italian.

Cited by

• Effect of plateletcrit and methylenetetrahydrofolate reductase (MTHFR) C677T genotypes on folic acid efficacy in stroke prevention.
  Shi Y, Zhang Z, Wang B, Wang Y, Kong X, Sun Y, Li A, Cui Y, Zhang Y, Li J, Huo Y, Huang H. Shi Y, et al. Signal Transduct Target Ther. 2024 May 10;9(1):110. doi: 10.1038/s41392-024-01817-0. Signal Transduct Target Ther. 2024. PMID: 38724491 Free PMC article.
• Prevalence and predictors of low folate levels among stroke survivors in a country without mandatory folate food fortification: Analysis of a Ghanaian sample.
  Sarfo FS, Boateng R, Opare-Addo PA, Gyamfi RA, Nguah SB, Ovbiagele B. Sarfo FS, et al. J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107239. doi: 10.1016/j.jstrokecerebrovasdis.2023.107239. Epub 2023 Jul 20. J Stroke Cerebrovasc Dis. 2023. PMID: 37480805 Free PMC article.
• Higher S-adenosylhomocysteine and lower ratio of S-adenosylmethionine to S-adenosylhomocysteine were more closely associated with increased risk of subclinical atherosclerosis than homocysteine.
  Xiao J, You Y, Chen X, Tang Y, Chen Y, Liu Q, Liu Z, Ling W. Xiao J, et al. Front Nutr. 2022 Aug 10;9:918698. doi: 10.3389/fnut.2022.918698. eCollection 2022. Front Nutr. 2022. PMID: 36034911 Free PMC article.
• Do B Vitamins Enhance the Effect of _Omega_-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases? A Systematic Review of Clinical Trials.
  Zhu J, Xun PC, Kolencik M, Yang KF, Fly AD, Kahe K. Zhu J, et al. Nutrients. 2022 Apr 12;14(8):1608. doi: 10.3390/nu14081608. Nutrients. 2022. PMID: 35458173 Free PMC article. Review.
• Betaine Supplementation Attenuates S-Adenosylhomocysteine Hydrolase-Deficiency-Accelerated Atherosclerosis in Apolipoprotein E-Deficient Mice.
  Dai X, Liu S, Cheng L, Huang T, Guo H, Wang D, Xia M, Ling W, Xiao Y. Dai X, et al. Nutrients. 2022 Feb 8;14(3):718. doi: 10.3390/nu14030718. Nutrients. 2022. PMID: 35277077 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information